Extracorporeal Membrane Oxygenation with Danaparoid Sodium After Massive Pulmonary EmbolismBAUER, Christian; VICHOVA, Zuzana; FFRENCH, Patrick et al.Anesthesia and analgesia. 2008, Vol 106, Num 4, pp 1101-1103, issn 0003-2999, 3 p.Article

Danaparoid Sodium Attenuates the Effects of Heat StressHAGIWARA, Satoshi; IWASAKA, Hideo; SHINGU, Chihiro et al.The Journal of surgical research (Print). 2011, Vol 171, Num 2, pp 762-768, issn 0022-4804, 7 p.Article

LES THROMBOPÉNIES INDUITES PAR L'HÉPARINE (TIH) = HEPARIN-INDUCED THROMBOCYTOPENIABACCUS, Ch; HANS, P; BRICHANT, J. F et al.RMLG. Revue médicale de Liège. 2009, Vol 64, Num 9, issn 0370-629X, 450-456 [7 p.]Article

Inhibition of thrombin generation in recalcified plasmaSTIEF, Thomas W.Blood coagulation & fibrinolysis. 2007, Vol 18, Num 8, pp 751-760, issn 0957-5235, 10 p.Article

Treatment and Prevention of Heparin-lnduced Thrombocytopenia : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)WARKENTIN, Theodore E; GREINACHER, Andreas; KOSTER, Andreas et al.Chest. 2008, Vol 133, Num 6, issn 0012-3692, 340.S-380.S, SUPArticle

Overview of Heparin-Induced Thrombocytopenia. Diagnosis and Treatment in Europe with an Emphasis on FranceGRUEL, Yves; POUPLARD, Claire.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 27-36, issn 0094-6176, 10 p., SUP1Article

Effects of argatroban, danaparoid, and fondaparinux on trombin generation in heparin-induced thrombocytopeniaTARDY-PONCET, Brigitte; COMBE, Marion; PIOT, Michèle et al.Thrombosis and haemostasis. 2013, Vol 109, Num 3, pp 504-509, issn 0340-6245, 6 p.Article

Portal Vein Thrombosis Treated Using Danaparoid Sodium and Antithrombin IIIUCHIYAMA, T; HIROKAZU, Takahashi; NAKAJIMA, A et al.Hepato-gastroenterology. 2010, Vol 57, Num 97, pp 52-53, issn 0172-6390, 2 p.Article

In Vitro Effects of Argatroban, Lepirudin, Bivalirudin, and Danaparoid on Fibrin Gel PermeabilitySHU HE; WALLEN, Hakan; JOHNSSON, Hans et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 91-96, issn 0094-6176, 6 p., SUP1Article

Heparin-Induced Thrombocytopenia: Real-World IssuesLINKINS, Lori-Ann; WARKENTIN, Theodore E.Seminars in thrombosis and hemostasis. 2011, Vol 37, Num 6, pp 653-663, issn 0094-6176, 11 p.Article

Anticoagulation in Patients with Heparin-Induced Thrombocytopenia undergoing Percutaneous Coronary Angiography and Interventions : Drugs in interventional cardiologyJOOST, Alexander; KUROWSKI, Volkhard; RADKE, Peter W et al.Current pharmaceutical design. 2008, Vol 14, Num 12, pp 1176-1185, issn 1381-6128, 10 p.Article

The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysisSHU HE; BLOMBÄCK, Margareta; BARK, Niklas et al.Thrombosis and haemostasis. 2010, Vol 103, Num 5, pp 1076-1084, issn 0340-6245, 9 p.Article

Alternative anticoagulation with danaparoid in two pregnancies in a patient with former heparin-induced thrombocytopenia (HIT), homozygous factorV Leiden mutation, a history of venous thrombosis and recurrent pregnancy lossesSCHINDEWOLF, Marc; LINDHOFF-LAST, Edelgard.Thrombosis and haemostasis. 2008, Vol 99, Num 4, pp 776-778, issn 0340-6245, 3 p.Article

Antibodies to Heparin-Platelet Factor 4 Complex: Pathogenesis, Epidemiology, and Management of Heparin-Induced Thrombocytopenia in HemodialysisDAVENPORT, Andrew.American journal of kidney diseases. 2009, Vol 54, Num 2, pp 361-374, issn 0272-6386, 14 p.Article